| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
NEUROENDOCRINOLOGY |
First Department of Internal Medicine (S.I., Y.S., S.K., H.Y., K.T., H.A., Y.M., Y.O.), Nagoya University School of Medicine, Nagoya 466-8550, Japan; and Research Institute of Environmental Medicine (T.M.), Nagoya University, Nagoya 464-8601, Japan
Address all correspondence and requests for reprints to: Takashi Murase, M.D., Ph.D., Department of Teratology and Genetics, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. E-mail: . tmurase{at}riem.nagoya-u.ac.jp
GH secretagogue (GHS) is a small, synthetic compound that has the potential to stimulate GH release via its specific receptors (GHS-R). Ghrelin is a novel 28-amino acid peptide recently isolated from human and rat stomach, and it is thought to be the endogenous ligand for GHS-R. Ghrelin has a variety of physiological functions such as the stimulation of GH release or the increase of food intake by activating NPY neurons. In the present study, we investigated the effects of ghrelin on AVP release in conscious rats. Intracerebroventricular (icv) administration of ghrelin increased the plasma AVP concentration in a dose-dependent manner (11000 pmol/rat), and its effect was observed as late as 60 min after the administration. Icv injection of ghrelin caused no significant change in plasma osmolality, plasma volume, or arterial blood pressure. Iv administration of ghrelin (10 nmol/rat) also increased the plasma AVP concentration, which was accompanied by a significant decrease in arterial blood pressure. Pretreatment with antiserum against NPY significantly reduced the plasma AVP increase induced by icv administration of ghrelin. These results suggest that ghrelin plays a stimulatory role in AVP release, which is possibly mediated by NPY neurons.
This article has been cited by other articles:
![]() |
H. Hashimoto, H. Fujihara, M. Kawasaki, T. Saito, M. Shibata, H. Otsubo, Y. Takei, and Y. Ueta Centrally and Peripherally Administered Ghrelin Potently Inhibits Water Intake in Rats Endocrinology, April 1, 2007; 148(4): 1638 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kleinz, J. J. Maguire, J. N. Skepper, and A. P. Davenport Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man Cardiovasc Res, January 1, 2006; 69(1): 227 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ye, X. Li, Y. Chen, H. Sun, W. Wang, T. Su, L. Jiang, B. Cui, and G. Ning Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4388 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Brownley, K. C. Light, K. M. Grewen, E. E. Bragdon, A. L. Hinderliter, and S. G. West Postprandial Ghrelin Is Elevated in Black Compared with White Women J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4457 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugimura, T. Murase, S. Ishizaki, K. Tachikawa, H. Arima, Y. Miura, T. B. Usdin, and Y. Oiso Centrally Administered Tuberoinfundibular Peptide of 39 Residues Inhibits Arginine Vasopressin Release in Conscious Rats Endocrinology, July 1, 2003; 144(7): 2791 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura, T. Tsuchihashi, K. Fujii, I. Abe, and M. Iida Central Ghrelin Modulates Sympathetic Activity in Conscious Rabbits Hypertension, November 1, 2002; 40(5): 694 - 699. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |